Utama › Limfoma Sel B Besar Difus › South Dakota
Kajian klinikal Limfoma Sel B Besar Difus di South Dakota
3 kajian untuk Limfoma Sel B Besar Difus sedang mencari peserta di lokasi di South Dakota.
Bandar di South Dakota
Teks kajian rasmi (Bahasa Inggeris)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Avera Cancer Institute, Sioux Falls
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06500273A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Sanford Cancer Center ( Site 0143), Sioux Falls
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06717347Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Sanford Children's Hospital-Sanford Children's Specialty Clinic ( Site 1015), Sioux Falls
Mengambil pesertaFasa 1/2
6 Months – 25 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06395103Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.